Clinical Trial Update: Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer [NA]

View source ↗

Summary

Clinical trial comparing indocyanine green to a 99mTc-labeled radiotracer for axillary lymphatic mapping in early-stage breast cancer; completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 99mTc-labeled radiotracer (technetium-99m radiotracer)
• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage I Breast Cancer, Stage II Breast Cancer | NA | Status: COMPLETED | Results posted: 2020-10-22